Red Spring for Refining: Behind Delek's Losses in 1Q16
Analyst recommendations for Delek
So far in this series, we’ve examined Delek US Holdings’ (DK) 1Q16 earnings, conducted a segmental analysis, and checked in with DK’s stock reaction to the 1Q16 results. Now it’s time to explore the recommendations of the analysts covering DK’s stock.
The above table shows that eight of the 11 firms have rated Delek (DK) as “buy,” “overweight,” or “outperform.” The highest 12-month price target for DK stands at $30, indicating a whopping 114% gain from current levels. The remaining three firms have rated Delek as a “hold.” None of the above firms have given “sell” rating to Delek.
The average 12-month price target for DK stands at $21, indicating a 51% gain from current levels. DK’s lowest 12-month price target stands at $11, implying 21% loss from current levels.
The highest price target for DK was set by Cowen, whereas the lowest price target was specified by Piper Jaffray. RBC Capital Markets, Credit Suisse, Wolfe Research, and J. P. Morgan have given price targets equal to or exceeding $22 per share for DK. Macquarie, Goldman Sachs, and Piper Jaffray have given “neutral” recommendations on the stock.
Analyst recommendations for peers
By comparison, Alon USA Energy (ALJ), Marathon Petroleum (MPC), and CVR Refining (CVRR) have been rated as “buy” by 9%, 78%, and 14%, respectively, of the analysts surveyed.
If you are looking for exposure to value stocks, you might consider the iShares Russell 1000 Value ETF (IWD), which has ~13% exposure to energy sector stocks. IWD also has ~28% exposure to financial sector stocks, ~12% exposure to healthcare stocks, ~12% exposure to information technology stocks, and ~11% exposure to industrial sector stocks.
Browse this series on Market Realist: